Every once is a while you see a truly absurd move of a stock. Today is that day for ONXX. I just noticed that it crated down to close to $73 briefly today and then rebounded a bit. Looks like computerized trading gone amuck and or a major margin call occurred. In the end it is irrelevant as initial Carfilzomib sales greatly exceeded expectations with $19 million. Nexavar sales were in China were $27 million in Q3, which was a 29% increase of 2011, and a 10% increase over Q2 2012.